Contribution of lactate buffer, glucose and glucose degradation products to peritoneal injury in vivo.

Zareie, Mohammad; Hekking, Liesbeth H P; Welten, Angelique G A; Driesprong, Bas A J; Schadee-Eestermans, Inge L; Faict, Dirk; Leyssens, Anne; Schalkwijk, Casper G; Beelen, Robert H J; ter Wee, Piet M; van den Born, Jacob

Zareie, Mohammad; Hekking, Liesbeth H P; Welten, Angelique G A; Driesprong, Bas A J; Schadee-Eestermans, Inge L; Faict, Dirk; Leyssens, Anne; Schalkwijk, Casper G; Beelen, Robert H J; ter Wee, Piet M; van den Born, Jacob.

Affiliation

Zareie M; Department of Molecular Cell Biology, VU University Medical Center, 1007 MB Amsterdam, The Netherlands.

Nephrol Dial Transplant ; 18(12): 2629-37, 2003 Dec.

Article in En | MEDLINE | ID: mdl-14605288

Subject(s)

Dialysis Solutions/adverse effects; Glucose/adverse effects; Lactic Acid/adverse effects; Peritoneal Dialysis, Continuous Ambulatory/adverse effects; Peritoneal Diseases/pathology; Animals; Buffers; Glycation End Products, Advanced; Hydrogen-Ion Concentration; Male; Models, Animal; Omentum/pathology; Peritoneal Dialysis, Continuous Ambulatory/methods; Peritoneal Diseases/etiology; Peritoneum/pathology; Rats; Rats, Wistar

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Peritoneal Diseases / Dialysis Solutions / Peritoneal Dialysis, Continuous Ambulatory / Lactic Acid / Glucose Type of study: Etiology_studies Limits: Animals Language: En Journal: Nephrol Dial Transplant Journal subject: NEFROLOGIA / TRANSPLANTE Year: 2003 Document type: Article Affiliation country: Netherlands Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links